Purchase of laboratory and blood collection supplies
Closed Solicitation Posted
- Solicitation number
- RFQ-NIAID-24-2258526
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Place of performance
- Bethesda, Maryland 20814, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health is seeking to procure laboratory and blood collection supplies for the Vaccine Research Center (VRC) through a Request for Quotes (RFQ) numbered RFQ-NIAID-25-2258526. The solicitation covers a comprehensive list of specialized scientific supplies, including LUMITRAC 600 plates, microcentrifuge tubes, antibodies, screening tapes, reagents, and various syringes and needles necessary to support ongoing research experiments. This acquisition will be processed under Simplified Acquisition Procedures with full and open competition, targeting vendors in the Biological Product Manufacturing sector (NAICS 325414). The government will evaluate quotes based on technical capability to meet requirements and price competitiveness, with a stated delivery expectation of approximately 10 days after award. Quotes must be submitted electronically through the NIAID electronic SIMPLIFIED ACQUISITION SUBMISSION SYSTEM (eSASS) by May 12, 2025, at 10:00 am EST.
The solicitation is not set aside for any specific business category and will be open to all responsible sources. The place of performance is located at NIH, NIAID in Bethesda, MD 20814, with delivery designated as FOB Destination. While specific award value is not explicitly stated, the procurement will result in a firm fixed price purchase order. Vendors must be registered in the System for Award Management (SAM) and comply with multiple Federal Acquisition Regulation (FAR) provisions, including representations and certifications related to telecommunications equipment, confidentiality agreements, and various statutory requirements. The contract will incorporate standard FAR clauses such as 52.212-4 for commercial item terms and conditions, and 52.232-40 regarding accelerated payments to small business subcontractors. Potential contractors must carefully review and accept the comprehensive terms and conditions outlined in the solicitation, which reference multiple federal acquisition regulations and clauses.
Notice text
3 versions
Update #3 · Latest ·
Description:
This notice is a Combined Synopsis/Solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-25-2258526 and the solicitation is issued as a Request for Quotes (RFQ).
This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2025-03, January 17, 2025.
The North American Industry Classification System (NAICS) code for this procurement is NAICS: 325414 – Biological Product (Except Diagnostic) Manufacturing with a Size Standard of 1250 employees. The requirement is being competed full and open competition, un-restricted, and without a small business set-aside.
Vaccine Research Center (VRC) at the National Institutes of Health (NIH) was established to facilitate research in vaccine development. The VRC is dedicated to improving global human health through the rigorous pursuit of effective vaccines for human diseases. The VRC seeks to obtain Lab and blood collection supplies. These are necessary supplies to support ongoing research experiments.
Specifications of requirement:
LUMITRAC™ 600 plates Case of 40
Catalog# 82050-724
Quantity: 2 Cases of 40/Case
VWR Micro Centrifuge Tube with Flat Screw-Cap
Catalog# 16466-042
Quantity: 5 packs of 500/Pack
Microtube (0.5 mL)
Catalog# 76417-236
Quantity: 1 Case of 5000/Case
Magnesium acetate, 2M, 250 mL each Supplier Rigaku -1008335 (restricted product;
can only be purchased by approved Shipping Accounts; email Regulatory_Affairs@vwr.com
Catalog# 101443-722
Quantity: 3 Per each
Finntip™ 50
Catalog# 14224-024
Quantity:10 cases of 3840
Brilliant Violet 605™ anti-mouse IgD Antibody
Catalog# 10761-002
Quantity: 4 per each
Brilliant Violet 510™ anti-mouse Ly-6G/Ly-6C (Gr-1) Antibody
Catalog# 10759-188
Quantity: 4 per each.
Brilliant Violet 510™ anti-mouse F4/80 Antibody
Catalog# 10757-014
Quantity: 3 per each.
Brilliant Violet 510™ anti-mouse CD8a Antibody
Catalog# 10756-702
Quantity: 3 per each
Brilliant Violet 510™ anti-mouse CD4 Antibody
Catalog# 10019-044
Quantity: 3 Per each
Brilliant Violet 421™ anti-mouse CD19 Antibody
Catalog# 115538-BL
Quantity: 4 Per each
Brilliant Violet 711™ anti-mouse CD138 (Syndecan-1) Antibody
Catalog# 10757-304
Quantity: 4 Per each
PerCP/Cyanine5.5 anti-mouse CD95 (Fas) Antibody
Catalog# 76013-342
Quantity: 2 Per each
HSD5000 ScreenTape
Catalog# 76645-084
Quantity: 8 Per each
HSD5000 Reagents
Catalog# 76645-492
Quantity: 8 Per each
SureBlue™ TMB 1-Component Microwell Peroxidase Substrate
Catalog# 95059-286
Quantity: 8 Per each
Quality economy brand luer slip syringes with attached needle, air-tite
Catalog# 76124-672
Quantity: 5 boxes of 100/Box
Single use syringe/Bd precision glide needles combinations, sterile
Catalog# BD309571
Quantity: 1 Case of 800/Case
Delivery date: Within approximately 10 days.
Place of Performance: NIH, NIAID, Bethesda, MD 20814
FOB: Destination
The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the following: technical capability to meet the requirements and price.
By submitting a quote in response to this solicitation, vendor is accepting the following terms and conditions:
The following FAR provisions apply to this acquisition:
FAR 52.212-1 Instructions to Offerors Commercial Items (SEP 2023)
FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (MAY 2024)
FAR 52.204-7 System for Award Management (OCT 2018)
(Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure FAR 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record)
FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (JAN 2017)
52.204–26 Covered Telecommunications Equipment or Services-Representation
(OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26
The following FAR contract clauses apply to this acquisition:
FAR 52-212-4 Contract Terms and Conditions Commercial Items (NOV 2023)
FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (NOV 2024)
*The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.
FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (MAR 2023)
FAR 52.204-13 System for Award Management Maintenance (OCT 2018)
FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (NOV 2021)
HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 2015)
FAR 52.252-2 -- Clauses Incorporated by Reference. (Feb 1998)
This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: http://farsite.hill.af.mil/vffara.htm
By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).
Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax.
Submission shall be received not later than Monday, 05/12/2025 at 10:00 am EST
All quotations and required documents must be submitted via the NIAID electronic SIMPLIFIED ACQUISITION SUBMISSION SYSTEM (eSASS) website at https://esass.nih.gov. All vendors must register in the eSASS system to submit a quotation. Instructions on how to register / submit quotes are included on the website. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responsible sources may submit an offer that will be considered by this Agency.
Update #2 ·
Description:
This notice is a Combined Synopsis/Solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-25-2258526 and the solicitation is issued as a Request for Quotes (RFQ).
This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2025-03, January 17, 2025.
The North American Industry Classification System (NAICS) code for this procurement is NAICS: 325414 – Biological Product (Except Diagnostic) Manufacturing with a Size Standard of 1250 employees. The requirement is being competed full and open competition, un-restricted, and without a small business set-aside.
Vaccine Research Center (VRC) at the National Institutes of Health (NIH) was established to facilitate research in vaccine development. The VRC is dedicated to improving global human health through the rigorous pursuit of effective vaccines for human diseases. The VRC seeks to obtain Lab and blood collection supplies. These are necessary supplies to support ongoing research experiments.
Specifications of requirement:
LUMITRAC™ 600 plates Case of 40
Catalog# 82050-724
Quantity: 2 Cases of 40/Case
VWR Micro Centrifuge Tube with Flat Screw-Cap
Catalog# 16466-042
Quantity: 5 packs of 500/Pack
Microtube (0.5 mL)
Catalog# 76417-236
Quantity: 1 Case of 5000/Case
Magnesium acetate, 2M, 250 mL each Supplier Rigaku -1008335 (restricted product;
can only be purchased by approved Shipping Accounts; email Regulatory_Affairs@vwr.com
Catalog# 101443-722
Quantity: 3 Per each
Finntip™ 50
Catalog# 14224-024
Quantity:10 cases of 3840
Brilliant Violet 605™ anti-mouse IgD Antibody
Catalog# 10761-002
Quantity: 4 per each
Brilliant Violet 510™ anti-mouse Ly-6G/Ly-6C (Gr-1) Antibody
Catalog# 10759-188
Quantity: 4 per each.
Brilliant Violet 510™ anti-mouse F4/80 Antibody
Catalog# 10757-014
Quantity: 3 per each.
Brilliant Violet 510™ anti-mouse CD8a Antibody
Catalog# 10756-702
Quantity: 3 per each
Brilliant Violet 510™ anti-mouse CD4 Antibody
Catalog# 10019-044
Quantity: 3 Per each
Brilliant Violet 421™ anti-mouse CD19 Antibody
Catalog# 115538-BL
Quantity: 4 Per each
Brilliant Violet 711™ anti-mouse CD138 (Syndecan-1) Antibody
Catalog# 10757-304
Quantity: 4 Per each
PerCP/Cyanine5.5 anti-mouse CD95 (Fas) Antibody
Catalog# 76013-342
Quantity: 2 Per each
HSD5000 ScreenTape
Catalog# 76645-084
Quantity: 8 Per each
HSD5000 Reagents
Catalog# 76645-492
Quantity: 8 Per each
SureBlue™ TMB 1-Component Microwell Peroxidase Substrate
Catalog# 95059-286
Quantity: 8 Per each
Quality economy brand luer slip syringes with attached needle, air-tite
Catalog# 76124-672
Quantity: 5 boxes of 100/Box
Single use syringe/Bd precision glide needles combinations, sterile
Catalog# BD30951
Quantity: 1 Case of 800/Case
Delivery date: Within approximately 10 days.
Place of Performance: NIH, NIAID, Bethesda, MD 20814
FOB: Destination
The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the following: technical capability to meet the requirements and price.
By submitting a quote in response to this solicitation, vendor is accepting the following terms and conditions:
The following FAR provisions apply to this acquisition:
FAR 52.212-1 Instructions to Offerors Commercial Items (SEP 2023)
FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (MAY 2024)
FAR 52.204-7 System for Award Management (OCT 2018)
(Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure FAR 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record)
FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (JAN 2017)
52.204–26 Covered Telecommunications Equipment or Services-Representation
(OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26
The following FAR contract clauses apply to this acquisition:
FAR 52-212-4 Contract Terms and Conditions Commercial Items (NOV 2023)
FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (NOV 2024)
*The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.
FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (MAR 2023)
FAR 52.204-13 System for Award Management Maintenance (OCT 2018)
FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (NOV 2021)
HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 2015)
FAR 52.252-2 -- Clauses Incorporated by Reference. (Feb 1998)
This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: http://farsite.hill.af.mil/vffara.htm
By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).
Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax.
Submission shall be received not later than Monday, 05/12/2025 at 10:00 am EST
All quotations and required documents must be submitted via the NIAID electronic SIMPLIFIED ACQUISITION SUBMISSION SYSTEM (eSASS) website at https://esass.nih.gov. All vendors must register in the eSASS system to submit a quotation. Instructions on how to register / submit quotes are included on the website. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responsible sources may submit an offer that will be considered by this Agency.
Update #1 ·
Description:
This notice is a Combined Synopsis/Solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-25-2258526 and the solicitation is issued as a Request for Quotes (RFQ).
This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2025-03, January 17, 2025.
The North American Industry Classification System (NAICS) code for this procurement is NAICS: 325414 – Biological Product (Except Diagnostic) Manufacturing with a Size Standard of 1250 employees. The requirement is being competed full and open competition, un-restricted, and without a small business set-aside.
Vaccine Research Center (VRC) at the National Institutes of Health (NIH) was established to facilitate research in vaccine development. The VRC is dedicated to improving global human health through the rigorous pursuit of effective vaccines for human diseases. The VRC seeks to obtain Lab and blood collection supplies. These are necessary supplies to support ongoing research experiments.
Specifications of requirement:
LUMITRAC™ 600 plates Case of 40
Catalog# 82050-724
VWR Micro Centrifuge Tube with Flat Screw-Cap
Catalog# 16466-042
Microtube (0.5 mL)
Catalog# 76417-236
Magnesium acetate, 2M, 250 mL each Supplier Rigaku -1008335 (restricted product;
can only be purchased by approved Shipping Accounts; email Regulatory_Affairs@vwr.com
Catalog# 101443-722
Finntip™ 50
Catalog# 14224-024
Brilliant Violet 605™ anti-mouse IgD Antibody
Catalog# 10761-002
Brilliant Violet 510™ anti-mouse Ly-6G/Ly-6C (Gr-1) Antibody
Catalog# 10759-188
Brilliant Violet 510™ anti-mouse F4/80 Antibody
Catalog# 10757-014
Brilliant Violet 510™ anti-mouse CD8a Antibody
Catalog# 10756-702
Brilliant Violet 510™ anti-mouse CD4 Antibody
Catalog# 10019-044
Brilliant Violet 421™ anti-mouse CD19 Antibody
Catalog# 115538-BL
Brilliant Violet 711™ anti-mouse CD138 (Syndecan-1) Antibody
Catalog# 10757-304
PerCP/Cyanine5.5 anti-mouse CD95 (Fas) Antibody
Catalog# 76013-342
HSD5000 ScreenTape
Catalog# 76645-084
HSD5000 Reagents
Catalog# 76645-492
SureBlue™ TMB 1-Component Microwell Peroxidase Substrate
Catalog# 95059-286
Quality economy brand luer slip syringes with attached needle, air-tite
Catalog# 76124-672
Single use syringe/Bd precision glide needles combinations, sterile
Catalog# BD30951
Delivery date: Within approximately 10 days.
Place of Performance: NIH, NIAID, Bethesda, MD 20814
FOB: Destination
The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the following: technical capability to meet the requirements and price.
By submitting a quote in response to this solicitation, vendor is accepting the following terms and conditions:
The following FAR provisions apply to this acquisition:
FAR 52.212-1 Instructions to Offerors Commercial Items (SEP 2023)
FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (MAY 2024)
FAR 52.204-7 System for Award Management (OCT 2018)
(Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure FAR 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record)
FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (JAN 2017)
52.204–26 Covered Telecommunications Equipment or Services-Representation
(OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26
The following FAR contract clauses apply to this acquisition:
FAR 52-212-4 Contract Terms and Conditions Commercial Items (NOV 2023)
FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (NOV 2024)
*The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.
FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (MAR 2023)
FAR 52.204-13 System for Award Management Maintenance (OCT 2018)
FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (NOV 2021)
HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 2015)
FAR 52.252-2 -- Clauses Incorporated by Reference. (Feb 1998)
This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: http://farsite.hill.af.mil/vffara.htm
By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).
Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax.
Submission shall be received not later than Monday, 05/12/2025 at 10:00 am EST
All quotations and required documents must be submitted via the NIAID electronic SIMPLIFIED ACQUISITION SUBMISSION SYSTEM (eSASS) website at https://esass.nih.gov. All vendors must register in the eSASS system to submit a quotation. Instructions on how to register / submit quotes are included on the website. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responsible sources may submit an offer that will be considered by this Agency.
Files
| File | Type | Posted |
|---|---|---|
| 2_RFQ-NIAID-25-2258526_Terms_and_Conditions_FAR_52.212-5.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside | |
| 6550-- Roche Ventana Reagents IDIQ 5 Successive 1 Year Delivery Orders | Veterans Integrated Service Network 16 | No set-aside | |
| Blood collecting-cult | Medical Supply Chain | No set-aside | |
| 6550--Blood Type IVD Reagents | Veterans Integrated Service Network 22 | No set-aside | |
| CSS - Upgrading PExA 2.1 to Vial-Based (PExA Cap) | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity